Chemical radioprotectors

Defence Science Journal

Volumn 55, Issue 4, 2005, Pages 403-425

  Upadhyay, S N ^a   Dwarakanath, B S ^a   Ravindranath, T ^a   Mathew, T L ^b  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b St Francis Hospital   (India)

Author keywords

Analogue Hoechst 33342; Bisbenzimidazole; Chemical radioprotectors; Herbal radioprotectors; Hoechst 33258; Radiation damage; Radiation injury; Radioprotectors; WR 2721

Indexed keywords

ANTIOXIDANTS; FREE RADICALS; NITROGEN COMPOUNDS; OXYGEN; RADIATION DAMAGE;

CHEMICAL RADIOPROTECTORS; HERBAL RADIOPROTECTORS; RADIATION INJURY; RADIOPROTECTORS;

RADIATION PROTECTION;

EID: 30644465951     PISSN: 0011748X     EISSN: None     Source Type: Journal    
DOI: 10.14429/dsj.55.2003     Document Type: Article

References (135)

1. Capizzi, R. Amifostine, the preclinical basis for broad spectrum selective cytoprotection of normal tissues from cytotoxic therapies. Seminars in Oncology, 1996, 23 (suppl 8). 2-17.
2. Uma Devi, P. Normal tissue protection in cancer therapy: Progress and prospects. Acta Oncology, 1998, 37(3), 247-52.
3. Weiss, J.F. & Landauer, M.R. Radioprotection by antioxidants. Annals of the New York Acad. Sci., 2000, 899, 44-60.
4. Wasserman, T. Radioprotective effects of amifostine. Seminars in Oncology, 1999, 26(2), (suppl 7). pp. 89-94.
5. Weiss, J.F. & Landeur, M.R. Protection against ionising radiation by antioxidant nutrients and phytochemicals. Toxicology, 2003, 189 (1-2), 1-20.
6. Alper, T. Cellular radiobiology. Cambridge University Press, London, 1979.
7. Carr, J.; Huff, J.E.; Fisher, K.D. & Huber, T.E. Protective agents modifying biological effects of radiation. Archives Environ. Health, 1970, 20, 88-98.
8. Chapman, J.D. & Reuvers, A.P. The time scale of radioprotection in mammalian cells. Experentia. 1977, 27(suppl), 9-18.
9. Edwards, J.C.; Chapman, D.; Cramp, W.A. & Yatvin, M.V. The effects of ionising radiation on biomembrane structure and function. Prog. Biophys. Mol. Biol., 1984, 43, 71-93.
10. Ferle Vidovic, A.; Petrovic, D.; Vidic, Z.; Osmak, M. & Kadizak, K. Absence of 2-aminoethyl isothiouronium bromide hydrobromide protection against fast neutrons: Cellular effects. Radiat. Environ. Biophys., 1981, 19, 197-04.
11. Singh, A. & Singh, H. Time scale and nature of radiation-biological damage: Approaches to radiation protection and post-irradiation therapy. Prog. Biophys. Mol. Biol., 1982, 39, 69-107.
12. Dwarakanath, B.S.; Adhikari, J.S. & Jain, V. Hematoporphyrin derivatives potentiate the radiosensitising effects of 2-DG in cancer cells. Int. J. Radiat. Oncol. Biol. Phys., 1998, 43, 1125-133.
13. Dwarakanath, B.S.; Koshi, L.; Raj, HJ.; Parmar, V.S. & Mathew, T.L. Acetylated phelyphenols as radiomodifiers. In International Conference on Biodiversity and Natural Products: Chemistry and Medical Applications, 26-31, 2004. Delhi. India.
14. Freeman, B.A. & Crapo, J.D. Biology of disease: Free radical and tissue injury. Laboratory Investigations, 1982, 47, 412-26.
15. Puck, T.T. & Marcus, P.I. Action of x-rays on mammalian cells. J. Exp. Med., 1956, 103, 653-66.
16. Ghose, A.; Ganguly, S.K. & Joginder Kaur. Protection with combination of hydroxytryptophan and some thiol compounds against wholebody gamma radiation. Int. J. Radiat. Biol., 1983, 44, 175-81.
17. Goel, H.C.; Ganguly, S.K.; Prasad, J. & Jain, V. Radioprotective effect of diltiazem on cytogenetic damage and survival in gamma ray-exposed mice. Ind. J. Exp. Biol., 1996, 34, 1194-2000.
18. Upadhyay, S.N.; Singh. S.; Bhardwaj, R.; Chaudhury, N.K. & Lazar Mathew, T. A preliminary study on 5-hydroxy-L-tryptophan, L-cysteine and cystamine. J. Ind. Chem. Soc., 2003, 80, 33-35.
19. Giambarresi, L. & Jacobs, A.J. Radioprotectants. In Military radiobiology, edited by J.J. Conklin and Richard. I. Walker. Academic Press Inc, New York, 1987. pp. 275-76.
20. Till, J.E. & Mc Culloch, E.A. Direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research, 1961, 14, 213-22.
21. Livesey, J.C.; Reed, D.J. & Adamson, L.F. Radiation protective drugs and their reaction mechanisms. Noyes Publications, Park Ridge, New Jersey, USA, 1985. pp.105-08.
22. Coia, L.; Krigel, R.; Hanks, G.; Comis, R.; Algazy, K.; Peters R.; Mc Culloch, W. & Sehein, P. A phase I study of WR 2721 in combination with total body irradiation in patients with refractory lymphoid malignancies. Int. J. Radiat. Oncol. Biol. Phys., 1992, 22, 791-94.
23. Mc Donald, S.; Meyerowitz, C.; Smutzin, T.B.S. & Rubin, P. Preliminary results of a pilot study using WR 2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. Int. J. Radiat. Oncol. Biol. Phys., 1994, 29(4), 747-54.
24. Liu, T.; Liu, Y.; He, S.; Zhang, Z. & Kliggerman, M.W. Use of radiation with or without WR 2721 in advanced rectal cancer. Cancer, 1992, 69, 2820-825.
25. Yuhas, J.M.; Proctor, J.O.; & Smith, L.H. Some pharmacologic effects of WR-2721: Their role in toxicity and radioprotection. Radiation Research, 1973, 54, 222-33.
26. 50 (30) doses. Radiation Research, 1970, 44, 621-28.
27. Yuhas, J.M. & Storer, J.B. Differential chemoprotection of normal and malignant tissues. J. Nat. Cancer Inst.(JNCI), 1969, 42, 331-35.
28. Borek, C. Nutritional, hormonal and enzymatic factors as modulators of radiation and chemical oncogenesis in vitro. In Radioprotectors and anticarcinogens, edited by O.P. Nygaard and M.G. Simic. Academic Press, New York, 1983. pp. 495-13.
29. Oberley, L.W. Modulation of cancer by Superoxide dismutase: Oncology overview. Pub. Int. Cancer Res. Databank (ICRDB), NCI, 1976.
30. Lucy, J.A. & Dingle, J.T. Fat-soluble vitamins and biological membrane. Nature, 1964, 204, 156-60.
31. Mc Cay, P.B. Vitamin E: Interactions with free radicals and ascorbate. Ann. Rev. Nature, 1985, 5, 323-40.
32. Bendicai, A. & Macailin, L.J. Safety of oral intake of vitamin E. Amer. J. clin. Nutri., 1988, 48, 612-19.
33. Chen, L.H. & Shiau C.A. Induction of glutathione S-transferase activity by antioxidants in hepatocyte culture. Anticancer Research, 1989, 9, 1069-072.
34. Satyamitra, M.; Uma Devi, P.; Murase, H. & Kagiya, V.T. In vivo post-irradiation protection by a vitamin analogue, alpha-TMG. M.G. Radiation Research, 2003, 160 (6), 655-61.
35. Nair, C.K.K.; Salvi, V.; Kagiya V.T.; & Rajagopalan, R. Relevance of radioprotectors in radiotherapy: Studies with tocopherol monoglucoside. J. Env. Pathol. Toxicology Oncol., 2004, 23, 153-60.
36. Denison, L.; Haigh, A.; Cunha, G. & Martin, R.F. DNA ligands as radioprotectors: Molecular studies with Hoechst 33342 and Hoechst 33258. Int. J. Radiat. Biol., 1992, 61(1), 69-81.
37. Adhikari, J.S.; Dwarakanath, B.S.; Khaitan, D.; Chandna, S.; Manickam, J.; Lazar, Mathew, T. & Jain, V. Heterogeneity in the radiobiological effects of DNA ligand Hoechst-33342 in human tumor cell lines. In Radiobiology: International Conference on Radiation Biology, 17-19 February 2000, Trivanndrum, India, 2000.
38. Singh. S.P.; Jayanth, V.R.; Chandna, S.; Dwarakanath, B.S.; Singh, S.; Adhikari, J.S. & Jain, V. Radioprotective effects of DNA ligands Hoechst-33342 and Hoechst-33258 in wholebody-irradiated mice. Ind. J. Exp. Biol., 1998, 36, 375-84.
39. Chaplin, D.J.; Durand, R.E. & Olive, P.L. Cell selection from a murine tumor using the fluorescent probe Hoechst-33342. Brit. J. Cancer, 1985, 51, 569-75.
40. Dwarakanath, B.S.; Kapoor, N.; Chandna, S.; Adhikari, J.S.; Singh, S. & Jain, V. Radiomodifying effects of DNA ligand Hoechst in transformed mammalian cells. In Trends in radiation and cancer biology, edited by R.N. Sharma. Bilateral Seminars of the International Bureau, Julich, 1998, 29, 81-89.
41. Dwarakanath, B.S.; Singh, S. & Jain, V. Optimisation of tumor radiotherapy, Part V: Radiosensitisation by 2-deoxy-D-glucose and DNA ligand Hoechst-33342 in a murine tumor. Ind. J. Exp. Biol., 1999, 37, 865-70.
42. Tawar, U.; Jain, K.A.; Dwarakanath, B.S.; Chandra, R.; Singh, Y.; Chaudhury, N.K.; Khaitan, D. & Tandon, V. Influence of phenyl ring disubstitution on bisbenzimidazole and terbenzimidazole cytotoxicity: synthesis and biological evaluation as radioprotectors. J. Med. Chem., 2003, 46, 3785-3792.
43. Klayman, D.L. & Copeland E.S. Radioprotective agents. In Kirk Othmer Encyclopedia of Chemical Technology Ed. 3, Vol. 9, edited by M. Grayson & D. Eckroth. Wiley, New York, 1982. pp. 801-32.
44. Copeland, E.S. Mechanisms of radioprotection. A review. Photochemistry Photobiology, 1978, 28, 839-44.
45. Revesz, L. & Modig, H. Cystamine-induced increase of cellular glutathione level: A new hypothesis of the radioprotective mechanism. Nature (London), 1965, 207, 430-31.
46. Modig, H.G. & Revesz, L. Non-protein sulphydryl and glutathione content of ehrlich ascites tumor cells after treatment with the radioprotectors AET, cysteamine, and glutathione. Int. J. Radiat. Biol., 1967, 13, 469-77.
47. Revesz, L; Edgren, M.; & Nishidai, T. Mechanisms of inherent radioprotection in mammalian cells. In Modification of radiosensitivity in cancer treatment, edited by T. Sugahara. Academic Press, New York, 1984. pp. 13-29.
48. Floesheim, G.L. Radioprotective effects of calcium antagonists used alone or with other types of radioprotectors. Radiation Research, 1993, 133, 80-87.
49. Upadhyay, S.N. A study on the physico-chemical characteristics of radioprotector dilitiazem and its binding with deoxyribonucleic acid and its constituent bases. J. Surface Sci. Technol., 2001, 17(3-4), 157-67.
50. Upadhyay, S.N.; Singh, S. & Ghose, A. Physico-chemical properties of a combination of 5-hydoxy-L-tryptophan with β-aminoethyl isothiouronium bromide hydrobromide. J.Ind. Chem. Soc., 1993, 70, 681-87.
51. 59Fe uptake in bone marrow after wholebody gamma irradiation to mice. Strahlentherapie 57, 1983, 59, 772-74.
52. Basu, S.K.; Chandra, K. & Chuttani, K. Radioprotection of peripheral blood cells with a combination of hydroxytryptophan and thiol compounds in mice. Acta Onkologica, 1987, 26, 229-32.
53. Basu, S.K.; Srinivasan, M.N.; Chuttani, K. & Ghose, A. Urinary deoxycitidine levels in radioprotected rats. J. Radiat. Res., 1984, 25, 174-82.
54. Srinivasan, M.N. & Basu, S.K. DNA synthesis in radioprotected rats after wholebody gamma irradiation. Ind. J. Nuclear Med., 1986, 1, 43-46.
55. Srinivasan, M.N.; Basu, S.K. & Ghose, A. Effect of chemical radioprotectors on serum proteins of rats exposed to gamma irradiation. Ind. J. Expl. Biol., 1985, 23, 490-92.
56. 59Fe uptake in blood in wholebody gamma irradiated rats. Radiobiologia Radiotherapia, 1987, 28, 507-09.
57. Dey, J.; Dey, T.B.; Ganguly, S.K.; Nagpal, K.K. & Ghose, A. Chemical radioprotection to bone marrow stem cells after wholebody gamma irradiation to mice. Strahlentherpie und Onkologie, 1988, 164, 681-83.
58. Upadhyay, S.N. Mechanism of radioprotection by 5-hydroxy-L-tryptophan. J. Ind. Chem. Soc., 2003, 80, 619-21.
59. Upadhyay, S.N.; Warrier, A.V. & Ghose, A. Effect of gamma irradiation on HT, 5-HT and HT + AET in in vitro system. J. Ind. Chem. Soc., 1993, 70, 763-67.
60. Upadhyay, S.N.; Singh, R.P. & Ghose, A. Stability study of 5-hydoxy-L-tryptophan and 5-hydroxytrptamine. Ind. J. Nuclear Med., 1987, 2, 90-91.
61. Upadhyay, S.N. & Guha, S.N. Mechanism of radioprotection by b-Amino-ethyl isothiouronium bromide hydrobromide. J. Ind. Chem. Soc., 2001, 78, 337-39.
62. Upadhyay, S.N.; Singh, R.P. & Ghose, A. Interaction of 5-hydoxy-L-tryptophan with deoxyribonucleic acid and nucleohistone. J. Surface Sci.& Technol., 1993, 9, 67-72.
63. Ghose, A. Radioprotection study with some radioprotectors in dogs and monkeys (Personal Communication).
64. Upadhyay, S.N.; Dey, T.B. & Ghose, A. Radioprotective efficacy of HT + AET in encapsulated form. Ind J. Exp. Biol., 1996, 34, 403-07.
65. Upadhyay, S.N.; Sharma, A.; Nagpal, K.K. & Saini, S.K. Effects of gamma irradiation on the concentration of 5-hydoxy-L-tryptophan and 5-hydroxytryptamine in presence of radioprotector in Sprague Dawley rats. Def. Sci. J., 1997, 47(4), 383-88.
66. Upadhyay, S.N. Search for a better radioprotective combined regimen. Ind. Photobiology Soc. (IPS) Newsletter, 2002, 41, 46-53.
67. Maisin, J.R. Protection against ionising radiation by combinations of radioprotectors. Pharmacology Therapeutics, 1988, 39, 189-93.
68. 50 (30) days. Radiation Research, 1986, 105, 276-81.
69. Floresheim, G.L. & Bieri, A. Further studies on selective radioprotection by organic Zn salts and synergism of Zn-aspartate with WR-2721. Brit. J. Radiolo., 1990, 63, 468-75.
70. Uma Devi, P. & Prasanna, P.G.S. Radioprotective effect of combinations of WR-2721 and mercaptoproionylglycine on mouse bone marrow chromosomes. Radiation Research, 1990, 124, 165-170.
71. Uma Devi, P. & Thomas, B. Bone marrow cell protection and modification of drug toxicity by combination of protectors. Pharmacology Therapentics, 1988, 39, 213-14.
72. Gnansoundari, A.; Uma Devi, P. & Rao, B.S.S. Enhancement of bone marrow radioprotection and reduction of WR-2721 toxicity by Ocimum sanctum. Mutation Research, 1998, 397, 303-42.
73. Patchen, M.L.; Alesandro, M.M.; Chitigos, M.A. & Weiss, J.F. Radioprotection by biological response modifiers alone and in combination with WR-2721. Pharmacology Therapeutics, 1988, 39, 247-54.
74. Bogo, V. Behavioural radioprotection. Pharmacology Therapeutics, 1988, 39, 73-78.
75. Mukherjee, S.K. Performance decrement by exposure to sub-lethal doses of ionising radiations. Def. Sci. J., 2000, 50(1), 63-74.
76. Wixon, H. N. & Hund, W.A. Ionising radiation decreases veratridine-stimulated uptake of sodium in rat brain synaptosomes. Science, 1983, 220, 1073-074.
77. Landauer, M.R.; Davis, H.D.; Dominitz, J.A. & Weiss, J.F. Dose and time relationships of the radioprotector WR-2721 on locomotor activity in mice. Pharmacol. Biochem. Behav., 1987, 27, 573-76.
78. Dubois, A; Fiala, N. & Bogo, V. Treatment of radiation-induced vomiting and gastric emptying suppression with zacopride. Gastroenterology, 1987, 92, 1376-380.
79. Conklin, J.J. & Hagon, M.P. Research issues for radiation protection for man in prolonged space flight. In Advances in radiation biology, Vol. 13, edited by Lett J.T. Academic Press, New York, 1987. pp. 215-84.
80. Young, R.W. In Mechanisms and treatment of radiation-induced nausea and vomiting: Mechanisms and treatment, edited by C.J Davis, C.J. Lake Bakkar, and G.V. Grahame Smith. Springer, New York, 1986. pp.94-109.
81. Mulhern, R.K.; Ochs, J. & Kum, L.E. Changes in intellect associated with cranial radiation therapy. In Radiation injury to the nervous system, edited by P.H. Gutin, S.A. Leibel, and E.G. Sheline. Raven Press, New York, 1991. pp. 325-40.
82. Sandhir, R. & Gill, K.D. Hepatoprotective effect of Liv 52 on ethanol induced liver damage in rats. Ind. J. Exp. Biol., 1999, 37, 762-66.
83. Uma Devi, P.; Ganasoundari, A.; Vrinda, B.; Srinivasan, K.K. & Unnikrishnan, M.K. Radiation protection by the ocimum flavonoids orientin and vicenin: Mechanisms of action. Radiation Research, 2000, 154, 455-60.
84. Uma Devi, P.; Ganasoundari, A.; Rao, B.S.S. & Srinivasan, K.K. In vivo radioprotection by ocimum flavonoids: Survival of mice. Radiation Research, 1999, 151, 74-78.
85. Ganapathi, N.G. & Jagetia, G.G. Liv 52 pretreatment inhibits the radiation-induced lipid peroxidation in mouse liver. Current Science, 1995, 69(7), 601-04.
86. Jagetia, G.G. & Ganapathi, N.G. Inhibition of clastogenic effect of radiation by Liv 52 in the bone marrow of mice. Mutation Research. 1989, 224(4), 507-10.
87. Samarth, R.M. & Ashok Kumar. Menthapiperita (Linn) leaf extract provides protection against radiation-induced chromosomal damage in marrow of mice. Ind. J. Exp. Biol., 2003, 41, 229-37.
88. Emerit, I.; Oganesian, N.; Sarkisian, T.; Arutyunyan, R.; Pogosian, A.; Ashian, K.; Levy, A. & Cernjavski, L. Clastogenic factors in the plasma of Chemobyl accident recovery: Anticlastogenic effect of Ginkgo biloba extract. Radiation Research, 1995, 144, 198-05.
89. Princemail, J.; Dupuis, M.; Nasar, C.; Hans, P.; Haag Berruier, M.; Anton, R. & Deby, C. Superoxide anion scavenging effect and Superoxide dismutase activity of Ginkgo biloba extract. Experimentia, 1989, 45(8), 708-12.
90. Inano, H.; Onode, M.; Inafuku, N.; Kubota, M.; Kamada, Y.; Osawa, T.; Kobayashi, H. & Wakabayashi, K. Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis, 2000, 21 (10), 1835-841.
91. Maisin, J.R. Chemical radioprotection: Past, present and future prospects (Bacq and Alexander Award Lecture). Int. J. Radiat. Biol., 1998, 73(4), 443-50.
92. Uma Devi, P.; Rao, B.S.S. & Solomon, F.E. Effect of plumbagin on the radiation-induced cytogenetic and cell cycle changes in mouse Ehrlich Ascites carcinoma in vivo. Ind J. Expl. Biol., 1998, 36, 891-95.
93. Goel, H.C.; Saji Kumar, S.; & Sharma, A.K. Effect of podophyllum hexandrum on radiation-induced delay of post-natal appearance of reflexes and physiological markers in rats irradiated in utero. Phytomedicine, 2002, 9, 447-54.
94. Mittal, A.; Pathania, V.; Agarwal, P.K.; Prasad, J.; Singh, S. & Goel, H.C. Influence of podophyllum hexandrum, an endogenous antioxidant defence system in mice: Possible role in radioprotection. Journal of Ethnopharmacology, 2001, 76, 253-62.
95. Uma Devi, P. & Vrinda, B. Radiation protection of human lymphocyte chromosomes in vitro by orientin and vicenin. Mutatation Research, 2001, 498, 39-46.
96. Judy, K.D.; Olivi, A. & Buahin, K.G. Effectiveness of controlled release of cyclophosphamide derivative with polymers against rat gliomas. Journal of Neurosurgery, 1995, 82, 481-86.
97. 6-glioma-bearing rats. Neurosurgery, 1996, 36, 117-24.
98. Malaker, K.; Hodson, D. & Hadzie, E. Management of radiation oesophagitis with gaviscon. J. Clin. Invest., 1988, 11 (suppl 4), 71-76.
99. Vuckovic-Dekic, L.J.; Susnjar, S.; Stanojevic Bakic, N.; Rajner, L. & Frim, O. The protective activity of thymexel against radiotherapeutically-induced cellular immunodepression in lung cancer patients. Neoplasma, 1992, 39, 171-76.
100. th International Conference on Chemical Modifiers of Cancer Treatment, 22-26 August1995, Christ Church, Oxford, UK, 1995.
101. Malakar, K.; Vijay, K.; Hodson, I. & Chambers, M. Radioprotective effect of vitamin E following radiotherapy for breast cancer. In Annual Meeting of the Radiation Research Society, March 20-25, Dallas, 1993.
102. Glover, D.; Grabelsky, S.; Fox, K.; Weiler, C.; Cannon, L. & Glick, J. Clinincal trials of WR-2721 and cisplatim. Int. J. Radiat. Oncol. Biol. Phys., 1989, 16, 1201-204.
103. Marberger, H.; Bartsch, G.; Huber, W.; Menander, K.B. & Schulte, T.L. Orgatein: A new drug for the treatment of radiation cystitis. Curr. Ther. Res. Clin. Exp., 1975, 18, 466-75.
104. Word, W.F.; Shih Hoellworth, A. & Johnson, P.M. Survival of penicillamine treated mice following wholebody irradiation. Radiation Research, 1980, 81, 131-37.
105. Kuna, P. Radioprotective and heamodynamic action of cystamine given intramuscularly in rats. Radiobiology Radiotherapentics, 1981, 22, 793-800.
106. Bird, R.P. Cysteamine as a protective agent with high LET radiations. Radiation Research, 1980, 82, 290-96.
107. Sweeny, T.R. A survival of compounds from the antiradiation drug development programme of the US Army Medical Research and Development Command, Walter Reed Army Research Institute, Washington DC, 1982. 359p.
108. Van der Meer, C. & van Bekkum, D.W. A study on the mechanism of radiation protection by 5-hydroxytryptamine & tryptamine. Int. J. Radiat. Biol., 1961, 4(1), 105-10.
109. Gupta, M.L.; Singh, R.P. & Uma Devi, U. Protection of mouse liver by 2-mercaptopropyonylglycine against β radiations from injected tritiated water. J. Radiat. Res., 1979, 20, 329-33.
110. Prasanna, P.G.S. & Uma Devi, P. Modification of WR 2721 radiation protection from gastrointestinal injury and death in mice by 2-mercaptopropyonylglycine. Radiation Research, 1993, 133, 111-15.
111. Garriott, M.L. & Crowe, D.T. AET reduces the frequency of micronuclei in bone marrow cells of mice exposed to gamma radiation. Radiation Research, 1983, 93, 200-04.
112. Revesz, L. ; Bergstrom, H. & Modig, H. Intrinsic non-protein sulphydryl levels and cellular radiosensitivity. Nature (London), 1963, 198, 1275-277.
113. Kolman, G.; Shapiro, B.; Leon, S. & Martin, D. The distribution and metabolism of the radiation protective agent aminopropylaminoethyl phosphorothioate (WR-2721) in mice. Report No AD-070993/1, 1978.
114. Roots, R. & Okada, S. Protection of DNA molecules of cultured mammalian cells from radiation-induced single strand scission by various alcohols and -SH compounds. Int. J. Radiat. Oncol. Biol. Phys., 1972, 21, 329-42.
115. Chapman, J.D.; Doern, S.D.; Ravers, A.P.; Gillespie, C.J.; Chatterjee, A.; Blakely, E.A.; Smith, K.C. & Tobias, C.A. Radioprotection by DMSO of mammalian cell exposed to x-rays and to heavily charged particle beams. Radiat. Environ. Biophys., 1919, 16, 29-41.
116. Upadhyay, S.N. Interaction of deoxyribonucleic acid with ß-Amino-ethyl isothiouronium bromide hydrobromide radiation protection and environment. Bull. Radiat. Protect., 1998, 21(1), 45-53.
117. Upadhyay, S.N. Interaction ß-amino-ethyl isothiouronium bromide hydrobromide with the bases of DNA, basic amino-acids and nucleohistone. J. Surface Sci. & Technol., 1999, 15(3-4) 137-46.
118. Alexander, P.; Dean, C.J.; Lehmann, A.R.; Ormerod, M.G.; Felds-criber, P. & Serianni, R.W. In Radiation protection and sensitisation, edited by H.L. Moroson and M. Quintilliani. Barnes & Noble, New York, 1970. pp. 15-34.
119. Renson, J. Radioprotection de la souris par la 5-hydoxy-L-tryptamine et quelques substances voisines. Arch. Intern. Physiolog. Biochemie., 1960, 68, 531-37 (French).
120. Bloomberg, A.L.; Nelson, D.F.N.; Gramkowski, M.; Glover, D.; Glice, G.A. ; Yuhas, J.M. & Kligerman, M.M. Clinical trials of WR-2721 with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 1985, 8, 561-63.
121. Bogo, V.; Jacob, A.J. & Weiss, A.J. Behavioural toxicity and efficacy of WR-2721 as radioprotector. Radiation Research, 1985, 104, 182-90.
122. Saini, S.K.; Dey, J.; Dey, T.B.; Sharma, A.K.; Ganguly, S.K.; Upadhyay, S.N. & Khanna, C.M. A preliminary combined regimen study of some radioprotectors with a lethal dose of gamma radiation. Ind. J. Nucl. Medi., 1994, 19(4), 246-50.
123. Booth, V.K.; Roberts, J.C.; Warters, R.C.; Wilmore, B.H. & Lepock, J.R. Radioprotective thiolamines WR-1065 and WR-33278 selectively denature nonhistone nuclear proteins. Radiation Research, 2000, 153, 813-22.
124. Yuhas, J.M. & Storer, J.B. Differential chemoprotection of normal and malignant tissues. J. Natl. Cancer Inst., 1969, 42, 621-28.
125. Malick, M.A.; Roy, R.M. & Sternberg, J. Effect of vitamin E on post-irradiation death in mice. Experentia, 1978, 34, 1216-217.
126. Srinivasan, V. & Weiss, J.F. Radioprotection by vitamin E: Injectable vitamin E administered alone or with WR-3684 enhances survival of irradiated mice. Int. J. Radiat. Oncol. Biol. Phys., 1992, 23, 841-45.
127. Ainswoth, E.J. From endotoxin to newer immunomodulators: Survival promoting effects of microbial polysaccharides complexes in irradiated mice. Pharmacological Therapy, 1988, 39, 223-25.
128. Neta, R. Role of cytokines in radioprotection. Pharmacological Therapy, 1988, 39, 261-66.
129. Casterlli, M.P.; Black, P.L. & Schneider, M. Protective, restorative and therapeutic properties of recombinant human IL1 in rodent models. Journal of Immunology, 1988, 140, 3830-833.
130. Ghose, A.; Ganguly, S.K.; Dey, J. & Mathur, M. Radioprotectors to mice by combination of hydroxytryptophan with AET or MPG. Bone marrow histology study. Radiobiologya Radiotherapia, 1987, 28, 477-82.
131. Basu, S.K.; Srinivasan, M.N.; Chuttani, K. & Ghose, A. Evaluation of some radioprotectors by the survival study of rats exposed to lethal dose of wholebody gamma irradiation. J. Radiat. Res., 1985, 26, 395-03.
132. Basu, S.K.; Srinivasan, M.N.; Chuttani, K.; Bhatnagar, A.; Ghose, A. & Chandra, K. Rat tissue GSH level and glutathione reductase activity in radiopotected rats. Bull. Radiat. Protect., 1986, 9, 185-88.
133. + influx study in RBC of lethally irradiated rats. Strahlentherapie, 1984, 160, 565-66.
134. Srinivasan, M.N. & Basu, S.K. Effect of radioprotectors on the altered DNA content in rats tissues following wholebody gamma irradiation. Radiobiology Radiotherapy, 1988, 29, 421-27.
135. Srinivasan, M.N.; Sarin, R.C. & Basu, S.K. Protection to testicular activity by a combination of 5-hydoxy-L-tryptophan with a thiol compound in wholebody gamma irradiated rats. Ind. J. Exp. Biol., 1989, 27, 640-43.